eMUDHRA IPO GMP, Grey Market Premium Today

eMUDHRA IPO GMP is not started yet, check this page for the latest IPO GMP, Kostak rates and Subject to Sauda rates. eMUDHRA IPO subscription to starts on 20 May 2022 and will close on 24 May 2022. The IPO consists of initial public offer of up to 1,64,60,908 Equity Shares of ₹ 5 (aggregating up to ₹ 412.79 Crore) and an offer for sale of up to 9,835,394 Equity Shares. The price range for the offer has been fixed at ₹ 243 – ₹ 256 per share.

eMUDHRA IPO GMP Today – Grey Market Premium

DateGrey Market Premium (Rs)Kostak  (Rs)Subject to Sauda (Rs)
17-05-2022₹ –₹ –₹ –
16-05-2022₹ –₹ –₹ –
15-05-2022₹ –₹ –₹ –
14-05-2022₹  ₹  

eMUDHRA IPO Price – Details

DescriptionEMUDHRA IPO Details
Public IssueInitial Public Issue of upto 1,64,60,908 Equity Shares of ₹ 5 (aggregating up to ₹ 412.79 Crore) and an offer for sale of up to 9,835,394 Equity Shares
Issue Open  Date20-May-22
Issue Close Date24-May-22
Issue TypeBook Building
IPO Price Band₹ 243 – ₹ 256
Face Value ₹ 5
Market Lot 58 Equity Shares and in multiples thereof
Minimum Order Quantity 58 Equity Shares
Maximum Subscription Amount for Retail InvestorRs. 2,00,000
Listing NSE, BSE
NSE SymbolEMUDHRA
IPO Market Timings 10.00 a.m. to 5.00 p.m.

eMUDHRA IPO GMP – FAQs

How much is eMUDHRA IPO GMP Today?

The eMUDHRA IPO GMP is Rs.0 at the moment

How much is eMUDHRA IPO Kostak Rate Today?

How much is eMUDHRA IPO Kostak Rate Today?

How much is eMUDHRA IPO Kostak Rate Today?

The eMUDHRA IPO Subject to Sauda is Rs.0

Disclaimer

This IPO GMP is only for information purposes only, we do not guarantee 100% accuracy in the GMP, it may change from time to time. Please consult your financial advisor before investing.

Investment/Trading in the securities market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equities, Derivatives, commodities, and Currency can be substantial.

Follow us on Telegram for all the latest updates

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles